As the market gets set for its next explosive run, four cryptocurrencies will be at the top of the list of market analysts ...

The SEC postpones its verdict on Grayscale’s Litecoin ETF bid, adding to delays as crypto ETF competition intensifies amid ...

Charlie Lee and GSR acted as lead investors, alongside participation from the Litecoin Foundation and prominent crypto ...

Litecoin (LTC), one of the oldest and most recognized cryptocurrencies, is showing renewed strength in the market, surging ...

MEI Pharma commits $100M to Litecoin with Charlie Lee joining its board, signaling major institutional interest in LTC.

LTC gained more than 12% in the past 24 hours, following two major institutional announcements. First and foremost, Luxxfolio Holdings confirmed increasing its LTC treasury by 151.6% per share, ...

MEI Pharma unveils a $100M Litecoin treasury initiative, gaining Litecoin Foundation support and boosting shares 50% intraday ...

GSR, crypto's capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc.

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

“There is already meaningful institutional interest in Litecoin, but few mechanisms exist to access it in a secure and structured way,” said Quynh Ho, Head of Venture Investment, GSR.